American Academy of Dermatology Issues First Pediatric Atopic Dermatitis Guidelines Highlighting Prevention and Expanded Therapies Written By Dr. Kamal Kant Kohli13 April 2026 8:15 PM ISTThe American Academy of Dermatology's first pediatric atopic dermatitis guidelines note limited evidence for most preventive interventions, with early...
Zasocitinib Shows Strong Efficacy in Plaque Psoriasis in Phase 3 trials Written By Dr. Kamal Kant Kohli7 April 2026 8:30 PM ISTTwo Phase 3 clinical studies evaluated the efficacy and safety of zasocitinib in patients with moderate to severe plaque psoriasis and found promising...
Dermatologists Warn Collagen Supplements May Not Deliver Expected Skin Benefits Written By Dr. Bhumika Maikhuri2 Feb 2026 8:30 AM ISTCollagen Supplements Aren't the Skin Miracle They Claim to Be, Experts Say. Collagen powders and pills have flooded the beauty aisle, promising...
Spesolimab Shows Promise for Generalized Pustular Psoriasis: Study Dr. Kamal Kant Kohli31 March 2025 9:15 PM ISTPost-hoc analyses of the EFFISAYIL 2 trial revealed improvements in Psoriasis Symptom Scale (PSS), Pain Visual Analog Scale (VAS), and Dermatology...
American Academy of Dermatology releases new guidelines of care for management of acne vulgaris Written By Medha Baranwal2 April 2024 1:30 AM ISTUSA: The American Academy of Dermatology (AAD) has released recent guidelines of care for the clinical management of patients with acne vulgaris.The...
Children with atopic dermatitis experience hindered growth compared to peers: PEDISTAD trial Written By Medha Baranwal26 March 2024 7:00 PM ISTUSA: Recent data from the PEDISTAD study showed a negative impact of moderate-to-severe atopic dermatitis (AD) on growth in children aged <12...
Lebrikizumab demonstrates efficacy in atopic dermatitis and skin of color patients in first of its kind study Written By Dr. Kamal Kant Kohli11 March 2024 2:30 AM ISTAtopic dermatitis (AD) is a chronic inflammatory skin disorder with limited treatment options for adolescents with moderate-to-severe disease. ...
Berdazimer gel 10.3 % found effective in clearing molluscum lesions in phase 3 SIMPLE clinical trial Written By Aditi23 March 2023 8:00 PM ISTUnited States: According to findings from phase 3 B-SIMPLE clinical trials, new data presented during the annual meeting of the American Academy of...
Rosacea patients may have increased odds of GERD, finds study Written By Medha Baranwal19 April 2022 9:00 AM ISTUSA: Recent data showed increased odds of gastroesophageal reflux disease (GERD) in rosacea patients compared to controls. Recognizing the association...
Sun Pharma arm presents phase 3 data for acne vulgaris cream WINLEVI at AAD meeting Ruchika Sharma26 March 2022 11:48 AM ISTWINLEVI is the first FDA-approved acne drug with a first-in-class mechanism of action in nearly 40 years.
Barcitinib effective in severe nail lichen planus-1st case report Dr. Nandita Mohan30 Dec 2021 5:40 PM ISTBarcitinib effective in severe nail lichen planus- 1st case report - Lichen planus (LP) is an inflammatory disorder of the skin and mucous membranes....
Benzoyl Peroxide and Retinol Regimen is Effective for Acne Vulgaris Written By MD Bureau18 May 2021 9:00 AM ISTBenzoyl peroxide is an FDA approved skincare ingredient that's widely used for the topical treatment of acne. In a recent study presented at the...
